• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

vaccine

	Next higher product group	pharmaceutical
	Status	1998-01-01 sales existent

Record changed: 2021-07-09

Advertisement

More documents for vaccine

• [1] Valneva S.E.. (7/6/21). "Press Release: Valneva Strengthens Management Team, Appoints Vincent Dequenne as SVP Operations and Joshua Drumm as VP Investor Relations". Saint-Herblain....
• [2] Sanofi S.A.. (6/29/21). "Press Release: Sanofi Launches Dedicated Vaccines mRNA Center of Excellence. Approximately €400million Investment Annually". Paris....
• [3] CureVac N.V.. (6/16/21). "Press Release: CureVac Provides Update on Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA....
• [4] BioNTech SE. (6/10/21). "Press Release: Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations". New York, NY & Mainz....
• [5] Moderna, Inc.. (6/1/21). "Press Release: Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands". Albstadt....
• [6] Ziphius Vaccines N.V.. (5/25/21). "Press Release: Ziphius Vaccines Raises €29.3M in Oversubscribed Series A Financing"....
• [7] Valneva S.E.. (5/10/21). "Press Release: Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $107.6 Million". Saint-Herblain....
• [8] Valneva S.E.. (4/29/21). "Press Release: Valneva Announces Launch of Proposed Global Offering, Start of the Roadshow and Nasdaq Listing". Saint-Herblain....
• [9] DNA Script. (4/27/21). "Press Release: DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA". Paris & Cambridge, MA....
• [10] Valneva S.E.. (4/6/21). "Press Release: Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001". Saint-Herblain....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.